An international team of scientists say they’ve successfully drilled one of the oldest ice cores yet, penetrating nearly 2 ...

Madrigal Pharmaceuticals' strong launch is confirmed with impressive sales in Q1 and Q2. Learn why MDGL stock could benefit ...

A will be implemented. Manual entry of HSN codes will no longer be allowed, with taxpayers required to select codes from a ...

An “elimination round” is likely to cull weaker players in a market dominated by EVs and plug-in hybrids. Among the early ...

Sabarimala Master Plan, emphasising cultural preservation, ecological restoration and better facilities for pilgrims, has ...

Transportation Secretary Jaime Bautista said the department is nearing a resolution to the right-of-way issue of Phase 2 of ...

Just when you thought there couldn’t be investor appetite for yet another GLP-1-focused obesity biotech, Verdiva Bio has ...

It’s part of a plan Mayor Joe Hogsett first announced in 2022 to revitalize the downtown space, including the market itself.

The advent of immunotherapy based on immune checkpoint inhibitors has improved the treatment of advanced hepatocellular ...

For several years, investigators have been studying combinations that include ruxolitinib, sold as Jakafi, to treat ...

CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...

With an aggregate of $11 million raised in an initial Series A funding round, Doron Therapeutics is advancing its lead ...